Get 25% discount on our yearly plans! Subscribe now
| Market Cap | - |
| Total Shares Outstanding | |
| Book Value | -3.69 |
| PE Ratio | - |
| PS Ratio | - |
| PB Ratio | - |
| Forward PE Ratio | - |
| ROIC | - |
| Return on Aseets | -62.13 |
| Return on Equity | -116.66 |
| Dividend | - |
| Dividend Yield | - |
| Total Assets | |
| Total Liability | |
| Assets-to-Libability Ratio |
| Total Current Assets | |
| Total Current Liability | |
| Current Ratio |
| Quick Ratio | |
| Debt to Equity Ratio |
| Net Income | - |
| EPS | - |
| EBITA | - |
| Gross Profit | - |
| Gross Profit Margin | - |
| Operating Margin | - |
| Net Profit Margin | - |
| 5 Days MA | 0.07 |
| 10 Days MA | 0.06 |
| 20 Days MA | 0.06 |
| 50 Days MA | 0.06 |
| 200 Days MA | 0.05 |
| 52 Weeks High | 0.13 |
| 52 Weeks low | 0.01 |
| All Time High | 0.13 |
| RSI | 55.55 |
| MACD | - |
| Shares Float | |
| Shares Short |
| % Short | |
| % Insider | - |
| % Institutions | - |
Biomotion Sciences Warrant (SLXNW)
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
Exchange: NASDAQ
IPO Date: 8/16/2024
Sector: Healthcare
Industry: Biotechnology
Employees: 0
Address: The Goldyne Savad Institute of Gene Therapy, Jerusalem, Israel, 9112001
| &ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | Totals | |
|---|---|---|---|---|---|---|---|
| Assets | 2.86K | 3.09K | 2.52K | 3.58K | 5.26K | 17.32K | |
| Current Assets | 2.25K | 3.05K | 2.31K | 3.34K | 4.98K | 15.93K | |
| Cash And Short Term Investments | 1.19K | 1.97K | 1.70K | 2.78K | 4.59K | 12.23K | |
| Other Current Assets | 1.06K | 1.07K | 618 | 558 | 384 | 3.70K | |
| Non Current Assets | 613 | 40 | 210 | 246 | 277 | 1.39K | |
| Non Currrent Assets Other | 53 | 5 | 30 | 30 | 30 | 148 | |
| Liabilities | 6.85K | 7.67K | 17.43K | 17.03K | 17.31K | 66.29K | |
| Current Liabilities | 3.52K | 3.58K | 2.36K | 1.94K | 2.20K | 13.61K | |
| Accounts Payable | 929 | 799 | 281 | 244 | 319 | 2.57K | |
| Short Long Term Debt | 1.00K | 229 | - | - | - | 1.23K | |
| Other Current Liabilities | 2.44K | 2.56K | 345 | 1.59K | 1.76K | 8.69K | |
| Non Current Liabilities | 3.33K | 4.08K | 15.06K | 15.09K | 15.12K | 52.68K | |
| Stockholder Equity | -2 | -4.58K | -18.26K | -16.82K | -15.48K | -55.13K | |
| Liabilities And Stockholders Equity | 2.86K | 3.09K | 2.52K | 3.58K | 5.26K | 17.32K | |
| Totals | 28.96K | 26.65K | 27.15K | 33.20K | 42.01K | 157.97K | |
| &ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | Totals | |
|---|---|---|---|---|---|---|---|
| Assets | 2.86K | 5.26K | 9.33K | 115.41K | 129.399 | 133.00K | |
| Current Assets | 2.25K | 4.98K | 8.84K | 407.797 | 51.701 | 16.53K | |
| Cash And Short Term Investments | 1.19K | 4.59K | 8.26K | 38.944 | 51.701 | 14.13K | |
| Other Current Assets | 1.06K | 384 | 580 | 368.853 | - | 2.40K | |
| Non Current Assets | 613 | 277 | 494 | 115.01K | 77.698 | 116.47K | |
| Non Currrent Assets Other | 53 | 30 | 30 | - | 77.698 | 190.69799999999998 | |
| Liabilities | 6.85K | 17.31K | 16.41K | 508.916 | 299.39 | 41.38K | |
| Current Liabilities | 3.52K | 2.20K | 1.61K | 348.576 | 29.4 | 7.71K | |
| Accounts Payable | 929 | 319 | 240 | - | - | 1.49K | |
| Short Long Term Debt | 1.00K | - | - | - | - | 1.00K | |
| Other Current Liabilities | 2.44K | 1.76K | 1.25K | 348.576 | 29.4 | 5.83K | |
| Non Current Liabilities | 3.33K | 15.12K | 14.80K | 160.34 | 269.99 | 33.68K | |
| Stockholder Equity | -2 | -15.48K | -10.66K | 114.91K | -169.99 | 88.59K | |
| Liabilities And Stockholders Equity | 2.86K | 5.26K | 9.33K | 115.41K | 129.399 | 133.00K | |
| Totals | 28.96K | 42.01K | 60.52K | 462.92K | 975.786 | 595.39K | |
| &ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | Totals | |
|---|---|---|
| Totals | - | |
| &ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | Totals | |
|---|---|---|
| Totals | - | |
| &ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 06/30/2023 | 03/31/2023 | Totals | |
|---|---|---|---|---|---|---|---|---|---|
| Cash From Operating Activities | -2.93K | -2.65K | -1.06K | -1.75K | -1.26K | -1.68K | -911 | -12.24K | |
| Net Income | -1.75K | -11.86K | -1.49K | -1.42K | -1.68K | -1.65K | -774 | -20.63K | |
| Depreciation | -12 | 22 | 7 | 8 | 6 | 14 | 15 | 60 | |
| Extraordinary Items | - | - | - | - | - | - | - | - | |
| Capital Expenditures | - | -16 | - | -6 | -4 | -2 | - | -28 | |
| Cash From Financing Activities | 2.18K | 2.92K | - | - | - | 522 | - | 5.63K | |
| Other Cashflows From Financing Activities | 2.80K | 2.30K | - | - | - | - | - | 5.10K | |
| Totals | 303 | -9.29K | -2.55K | -3.17K | -2.94K | -2.79K | -1.67K | -22.10K | |
| &ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | Totals | |
|---|---|---|---|---|---|---|
| Cash From Operating Activities | -8.40K | -4.53K | -3.33K | -1.41K | -17.67K | |
| Net Income | -16.52K | -5.11K | -3.49K | -755.218 | -25.87K | |
| Depreciation | 25 | 45 | 57 | - | 127 | |
| Extraordinary Items | - | - | - | - | - | |
| Capital Expenditures | -22 | -12 | -40 | -0.004 | -74.004 | |
| Other Cashflows From Investing Activities | - | 78 | - | - | 78 | |
| Cash From Financing Activities | 5.10K | 522 | 2.75K | 116.40K | 124.78K | |
| Other Cashflows From Financing Activities | 5.35K | -1.13K | 2.75K | -2.55K | 4.43K | |
| Totals | -14.45K | -10.13K | -1.30K | 111.69K | 85.80K | |
